Topic

Aetna (CVS Health)

A collection of 1076 issues

How to Get Oxlumo (Lumasiran) Covered by Aetna (CVS Health) in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Oxlumo Covered by Aetna (CVS Health) in Illinois Aetna (CVS Health) covers Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1) with prior authorization. To get approval: (1) Your nephrologist or geneticist submits a precertification request with confirmed PH1 diagnosis (genetic testing showing AGXT mutation or enzyme analysis)
6 min read

Renewing Tepezza (Teprotumumab) Approval with Aetna CVS Health in New York: Complete Guide to Documentation and Timelines

Answer Box: Renewing Tepezza Coverage Most Aetna CVS Health plans limit Tepezza to one 8-infusion course per lifetime. Renewal beyond 8 doses requires exceptional documentation showing unmet clinical need plus peer-reviewed evidence supporting extended treatment. Start renewal requests 2-4 weeks before your final scheduled infusion. If denied, New York residents
6 min read

Myths vs. Facts: Getting Garadacimab Covered by Aetna (CVS Health) in Washington - Complete Prior Authorization Guide

Answer Box: Getting Garadacimab Covered by Aetna in Washington Garadacimab requires prior authorization from Aetna (CVS Health) with confirmed HAE diagnosis, specialist prescription, and often documented failures of step-therapy alternatives. Washington residents have strong appeal rights through the Office of Insurance Commissioner, including expedited reviews (72 hours) and binding external
6 min read